Citation Tools
PDFBasic tumor immunology
Original research
Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity